Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2022 07:05 ET | Source: OraSure Technologies, Inc.

OraSure Technologies’ Subsidiary DNA Genotek Launches the First Device with De Novo Authorization from the FDA for the Preservation and Stabilization of Microbiome Samples

BETHLEHEM, Pa., April 07, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
March 31, 2022 07:05 ET | Source: OraSure Technologies, Inc.

OraSure Technologies’ Subsidiary Diversigen Launches Metatranscriptomic Sequencing and Analysis Services for Gut Microbiome Samples

BETHLEHEM, Pa., March 31, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
March 22, 2022 16:05 ET | Source: OraSure Technologies, Inc.

OraSure Director Nancy Gagliano Selected to Serve as Interim Chief Executive Officer; Brings Extensive Diagnostics and Healthcare Leadership Experience to Role

Board Continues Search for Permanent CEO Evaluation of Strategic Alternatives Ongoing BETHLEHEM, Pa., March 22, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader...
February 23, 2022 16:05 ET | Source: OraSure Technologies, Inc.

OraSure Technologies Reports 4Q21 Revenue of $63.6 Million; InteliSwab® Production Scales Up

Total 2021 revenue of $233.7 million, up 36% year-over year InteliSwab® receives emergency use authorization expansion and demonstrates accurate detection of Omicron variant InteliSwab® revenue of...
February 16, 2022 16:05 ET | Source: OraSure Technologies, Inc.

OraSure Technologies, Inc. 2021 Fourth Quarter Earnings Conference Call Wednesday, February 23, 2022, 5:00 p.m. ET

BETHLEHEM, Pa., Feb. 16, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering 2021 fourth quarter financial results and...
January 31, 2022 07:05 ET | Source: OraSure Technologies, Inc.

InteliSwab® COVID-19 Rapid Tests Receive U.S. FDA Authorization for Pediatric Use and Company Launches New InteliSwab® Connect Reporting App

Data Demonstrates InteliSwab® is Accurate, Easy to Use, and Well Accepted by Children BETHLEHEM, Pa., Jan. 31, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader...
January 25, 2022 07:05 ET | Source: OraSure Technologies, Inc.

OraSure Technologies, Inc. Expands HIV Oral Swab In-home Test into Europe

BETHLEHEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
January 13, 2022 16:05 ET | Source: OraSure Technologies, Inc.

InteliSwab® COVID-19 Rapid Tests Detect Omicron at Same Level as Other Variants

BETHLEHEM, Pa., Jan. 13, 2022 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a global leader in point-of-care and home diagnostic testing and sample collection technologies,...
January 05, 2022 07:05 ET | Source: OraSure Technologies, Inc.

OraSure Technologies Announces Actions to Enhance Stockholder Value

Provides Preliminary 4Q21 Financial OutlookCommences Review of Strategic AlternativesAnnounces Transition of CEO and Organizational ChangesBETHLEHEM, Pa., Jan. 05, 2022 (GLOBE NEWSWIRE) -- OraSure...
December 14, 2021 07:05 ET | Source: OraSure Technologies, Inc.

OraSure Technologies Announces 2022 Annual Meeting Date

BETHLEHEM, Pa., Dec. 14, 2021 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) today announced that its 2022 Annual Meeting of Stockholders is scheduled to be held at 10:00 a.m. EDT...